Clinical trials
CVD clinical trials
Below are recruiting cvd clinical trials, each written for real people, not researchers. We’re tracking 65 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06917131Recruiting
Can royal jelly help with high blood pressure?
This study tests if taking royal jelly, a natural substance made by bees, can reduce inflammation and stress in the body for people with high blood pressure (stage 1). It may help control blood pressure better.
Rio de Janeiro, Rio de JaneiroAges 18–75 - NCT06908590Recruiting
Community health worker help for heart rehab after a heart event
This trial tests whether a community health worker (a trained person from your community) can help people with low income join and stick with a heart rehab program after a heart event. The goal is to make heart recovery easier and more accessible.
Baltimore, MarylandAges 21 years+ - NCT06818669Recruiting
Heart risk study for Black adults with food insecurity
This study tests if giving small rewards for buying healthy food and taking medicines can lower heart disease risk in African American adults who have trouble getting enough food. You will get help with food costs and health coaching.
Buffalo, New YorkAges 18 years+ - NCT06811896Recruiting
Stress management for heart health in women with HIV
This study tests a stress management program designed to help reduce the risk of heart disease in women with HIV. Researchers want to see if learning stress reduction skills can improve heart health.
Birmingham, AlabamaAges 18 years+ - NCT05500859Recruiting
Registry for people in outpatient heart rehab programs
This study is a health registry that collects information about people taking part in outpatient (ambulatory) cardiac rehabilitation. It may help improve and organize future support, since your details can be used to understand outcomes and care needs.
BaselAges Any age - NCT06503341Recruiting
Preventive cardiology patient registry
This study is a registry that collects information from people who visit preventive cardiology clinics. It helps doctors learn more about heart disease prevention and how to better care for patients.
Karachi, SindhAges 18–90 - NCT06334666Enrolling by invitation
Step counting for fatty liver disease management
This trial tests if using a pedometer to track daily steps can help people with a type of fatty liver disease (called MASLD) become more active and improve their health. It may be a good fit if you are not already very active and want to try a simple way to manage your condition.
Bangkoknoi, BangkokAges 18 years+ - NCT06287229RecruitingPhase 1/Phase 2
CAR T therapy for B-cell ALL after initial treatment
This trial tests whether a special immune cell therapy (brexucabtagene autoleucel, or CAR T therapy) can help people with B-cell acute lymphocytic leukemia (ALL) after reducing the number of leukemia cells with a chemo-immunotherapy combination. It is for patients whose cancer has returned or is hard to treat, or for those newly diagnosed with a high-risk form of ALL.
Houston, TexasAges 18 years+ - NCT05645718RecruitingPhase 2
Chemo plus targeted antibodies for relapsed childhood B-ALL
This Phase 2 study tests a combination treatment for children, teens, or young adults whose B-cell acute lymphoblastic leukemia (B-ALL) has come back or did not respond to initial therapy. It may help patients who cannot safely receive certain standard medicines like anthracyclines or who cannot tolerate PEG-asparaginase.
Houston, TexasAges 1–25 - NCT05440422RecruitingPhase 2
Anifrolumab for heart health in lupus patients
This study tests whether anifrolumab, a drug that targets the immune system, can improve markers of blood vessel health in people with lupus. It may help reduce the risk of heart problems associated with lupus.
Bethesda, MarylandAges 18–80 - NCT05334888Recruiting
Study how sex and gut bacteria relate to heart risk
This study follows people over time to understand how sex-related factors and gut bacteria may affect heart and blood-vessel risk. It may help researchers identify who could benefit from earlier prevention, based on personal risk patterns.
BerlinAges 18–50 - NCT05288790RecruitingPhase 2
Study how gut chemicals and alcohol affect heart risk in HIV
This Phase 2 study looks at how “microbiome metabolites” (chemicals from gut bacteria) and alcohol may affect heart and blood vessel risk in people living with HIV. If you qualify, you may be asked to follow a study plan to see how these factors change health markers related to cardiovascular disease.
Nashville, TennesseeAges 18–89 - NCT04798430Enrolling by invitationPhase 3
Study drug follow-up for LDL reduction in high-risk cholesterol patients
This Phase 3 study looks at the long-term safety and benefit of OLE LIB003 for people with very high cholesterol or heart disease risk who still need lower LDL (“bad cholesterol”). It’s likely a continuation study for participants who already did earlier LIB003 Phase 3 trials.
Evanston, IllinoisAges 10 years+ - NCT04522765Recruiting
Tracking daily blood pressure patterns in people at high heart risk
This study measures how your blood pressure changes across the day in people at higher risk of heart and blood vessel disease. It may help researchers understand why blood pressure patterns vary, which could guide better prevention or care.
EdinburghAges 18–90 - NCT03971669RecruitingPhase 4
Blood donor study testing safety of donating in health
This trial studies people who donate blood and checks what happens in your body after donation, focusing on safety and measurements in lab tests. You may be able to join if you are healthy and pass screening labs and health history checks.
Baltimore, MarylandAges 18 years+ - NCT03705585RecruitingPhase 4
Check how typhoid and cholera vaccines work in adults
This study gives (or follows) typhoid and/or cholera vaccines and measures how your immune system responds. It is done in adults who are already scheduled for an upper endoscopy (EGD) and/or colonoscopy, using small tissue samples if appropriate.
Baltimore, MarylandAges 18 years+ - NCT02582021Recruiting
Study of treatments and imaging in women with angina or HFpEF
This trial studies how heart disease affects the heart using heart imaging, and looks at people with chest pain/angina or heart failure with preserved pumping strength (HFpEF). It may help doctors better understand what’s driving symptoms and how best to evaluate these conditions.
Los Angeles, CaliforniaAges 18 years+
Hear when a new CVD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cvd?
- Yes. Clin2 currently lists 65 recruiting cvd studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cvd trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cvd trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.